Patents by Inventor Lisa Zhao
Lisa Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11960683Abstract: A display system for sensing a finger of a user applied to the display system includes a display panel; a sensor for sensing the finger; a sensing light source configured to emit a first light having a first wavelength W1; and a reflective polarizer disposed between the display panel and the sensor. For a substantially normally incident light, an optical transmittance of the reflective polarizer versus wavelength for a first polarization state has a band edge such that for a first wavelength range extending from a smaller wavelength L1 to a greater wavelength L2 and including W1, where 30 nm?L2?L1?50 nm and L1 is greater than and within about 20 nm of a wavelength L3 corresponding to an optical transmittance of about 50% along the band edge, the optical transmittance has an average of greater than about 75%.Type: GrantFiled: May 4, 2021Date of Patent: April 16, 2024Assignee: 3M INNOVATIVE PROPERTIES COMPANYInventors: Bharat R. Acharya, Robert D. Taylor, Joseph P. Attard, Benjamin J. Forsythe, David T. Yust, Matthew E. Sousa, Jason S. Petaja, Anthony M. Renstrom, William Blake Kolb, Matthew S. Cole, Matthew S. Stay, Matthew R. D. Smith, Jeremy O. Swanson, Tri D. Pham, David A. Rosen, Qunyi Chen, Lisa A. DeNicola, Quinn D. Sanford, Carl A. Stover, Lin Zhao, Gilles J. Benoit
-
Patent number: 11928565Abstract: Methods and systems for building and maintaining model(s) of a physical process are disclosed. One method includes receiving training data associated with a plurality of different data sources, and performing a clustering process to form one or more clusters. For each of the one or more clusters, the method includes building a data model based on the training data associated with the data sources in the cluster, automatically performing a data cleansing process on operational data based on the data model, and automatically updating the data model based on updated training data that is received as operational data. For data sources excluded from the clusters, automatic building, data cleansing, and updating of models can also be applied.Type: GrantFiled: October 24, 2022Date of Patent: March 12, 2024Assignee: Chevron U.S.A. Inc.Inventors: Yining Dong, Alisha Deshpande, Yingying Zheng, Lisa Ann Brenskelle, Si-Zhao Qin
-
Patent number: 10729744Abstract: Disclosed are methods of influencing, and enhancing, cognitive function and memory by increasing, and/or preventing interference with, Reelin levels as well as Reelin signaling. Cognitive function is improved, in a subject in need thereof, by administering a therapeutically effective amount of Reelin, a Reelin-specific modulator or an agonist of a lipoprotein receptor to the subject. The lipoprotein receptor can be selected from candidates such as ApoER2 and VLDLR. As disclosed herein, agonists of the lipoprotein receptor for use with the inventive method include APC, Sep and Fc-RAP. In addition to administering exogenous Reelin, a Reelin-specific modulator, such as a recombinant Reelin fragment, can be used to increase Reelin levels and/or signaling.Type: GrantFiled: April 2, 2018Date of Patent: August 4, 2020Assignees: University of South Florida, Vanderbilt UniversityInventors: Edwin Weeber, Lisa Zhao, Melinda Peters
-
Publication number: 20180236028Abstract: Disclosed are methods of influencing, and enhancing, cognitive function and memory by increasing, and/or preventing interference with, Reelin levels as well as Reelin signaling. Cognitive function is improved, in a subject in need thereof, by administering a therapeutically effective amount of Reelin, a Reelin-specific modulator or an agonist of a lipoprotein receptor to the subject. The lipoprotein receptor can be selected from candidates such as ApoER2 and VLDLR. As disclosed herein, agonists of the lipoprotein receptor for use with the inventive method include APC, Sep and Fc-RAP. In addition to administering exogenous Reelin, a Reelin-specific modulator, such as a recombinant Reelin fragment, can be used to increase Reelin levels and/or signaling.Type: ApplicationFiled: April 2, 2018Publication date: August 23, 2018Applicants: University of South Florida, Vanderbilt UniversityInventors: Edwin Weeber, Lisa Zhao, Melinda Peters
-
Patent number: 9962426Abstract: Disclosed are methods of influencing, and enhancing, cognitive function by increasing, and/or preventing interference with, Reelin levels as well as Reelin signaling. Cognitive function is improved, in a subject in need thereof, by administering a therapeutically effective amount of Reelin, a Reelin-specific modulator or an agonist of a lipoprotein receptor to the subject. The lipoprotein receptor can be selected from candidates such as ApoER2 and VLDLR. As disclosed herein, agonists of the lipoprotein receptor for use with the inventive method include APC, Sep and Fc-RAP. In addition to administering exogenous Reelin, a Reelin-specific modulator, such as a recombinant Reelin fragment, can be used to increase Reelin levels and/or signaling.Type: GrantFiled: December 15, 2015Date of Patent: May 8, 2018Assignees: University of South Florida, Vanderbilt UniversityInventors: Edwin Weeber, Lisa Zhao, Melinda Peters
-
Publication number: 20160271213Abstract: Disclosed are methods of influencing, and enhancing, cognitive function by increasing, and/or preventing interference with, Reelin levels as well as Reelin signaling. Cognitive function is improved, in a subject in need thereof, by administering a therapeutically effective amount of Reelin, a Reelin-specific modulator or an agonist of a lipoprotein receptor to the subject. The lipoprotein receptor can be selected from candidates such as ApoER2 and VLDLR. As disclosed herein, agonists of the lipoprotein receptor for use with the inventive method include APC, Sep and Fc-RAP. In addition to administering exogenous Reelin, a Reelin-specific modulator, such as a recombinant Reelin fragment, can be used to increase Reelin levels and/or signaling.Type: ApplicationFiled: December 15, 2015Publication date: September 22, 2016Applicants: University of South Florida, Vanderbilt UniversityInventors: Edwin Weeber, Lisa Zhao, Melinda Peters
-
Patent number: 9241975Abstract: Disclosed are methods of influencing, and enhancing, cognitive function by increasing, and/or preventing interference with, Reelin levels as well as Reelin signaling. Cognitive function is improved, in a subject in need thereof, by administering a therapeutically effective amount of Reelin, a Reelin-specific modulator or an agonist of a lipoprotein receptor to the subject. The lipoprotein receptor can be selected from candidates such as ApoER2 and VLDLR. As disclosed herein, agonists of the lipoprotein receptor for use with the inventive method include APC, Sep and Fc-RAP. In addition to administering exogenous Reelin, a Reelin-specific modulator, such as a recombinant Reelin fragment, can be used to increase Reelin levels and/or signaling.Type: GrantFiled: August 9, 2011Date of Patent: January 26, 2016Assignees: University of South Florida, Vanderbilt UniversityInventors: Edwin Weeber, Lisa Zhao, Melinda Peters
-
Publication number: 20130304506Abstract: A method and system for tracking health care metrics over time is disclosed which involves aggregating health related data via computer in a common computer database, de-identifying persons in the data in the database to remove personally identifiable information (PII) and personal Health information (PHI), matching de-identified persons with the related data, analyzing the matched de-identified persons and related data to generate populations utilizing risk, condition, and appropriateness of care algorithms, stratifying the population into predefined groups, identifying opportunities for health improvement, disseminating the opportunities to the persons in the groups; and tracking the groups over time to ascertain success of the opportunities disseminated.Type: ApplicationFiled: March 14, 2013Publication date: November 14, 2013Applicant: Healthenic Inc.Inventors: Sean Gallivan, Herbert Ong, Harvey Kramer Hawks, Kei Wakabayashi, Lisa Zhao, Ryan Collier
-
Publication number: 20120058109Abstract: Disclosed are methods of influencing, and enhancing, cognitive function by increasing, and/or preventing interference with, Reelin levels as well as Reelin signaling. Cognitive function is improved, in a subject in need thereof, by administering a therapeutically effective amount of Reelin, a Reelin-specific modulator or an agonist of a lipoprotein receptor to the subject. The lipoprotein receptor can be selected from candidates such as ApoER2 and VLDLR. As disclosed herein, agonists of the lipoprotein receptor for use with the inventive method include APC, Sep and Fc-RAP. In addition to administering exogenous Reelin, a Reelin-specific modulator, such as a recombinant Reelin fragment, can be used to increase Reelin levels and/or signaling.Type: ApplicationFiled: August 9, 2011Publication date: March 8, 2012Applicants: VANDERBILT UNIVERSITY, UNIVERSITY OF SOUTH FLORIDAInventors: Edwin Weeber, Lisa Zhao, Melinda Peters